Alyftrek 10-50-125 MG tablet 14S
Ended Awarded
- Contract number
- SPE2DB25FF21V
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,993
Award facts
- Contract value 100% obligated
- $20,993.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 8, 2025, by the Defense Logistics Agency for ALYFTREK 10-50-125 mg tablets in quantities of 14 units. This firm fixed-price delivery order, valued at approximately $21,000, represents a single issuance under the company's larger Indefinite Delivery Contract with the DLA's SPE2DB program, which carries a total value of $500 million and remains valid through November 2026. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal procurement marketplace despite its status as a women-owned small business enterprise.
The delivery order is scheduled for completion by September 9, 2025, with performance taking place at the contractor's Park Ridge, Illinois location. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. This particular delivery order for ALYFTREK tablets supports the DLA's mission to supply medical products to military health facilities, continuing the contractor's established role as a primary pharmaceutical distributor for federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FF21V?
SPE2DB25FF21V was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FF21V worth?
The government has obligated $20,993 on SPE2DB25FF21V.
Is contract SPE2DB25FF21V an order under another contract?
Yes. SPE2DB25FF21V is a delivery order under SPE2DB20D9153, an indefinite delivery contract.
Was contract SPE2DB25FF21V competed?
The extent of competition for SPE2DB25FF21V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award